FOXG1 and glioblastoma: FoxG1 has been shown to inhibit expression of the cyclin-dependent kinase (CDK) inhibitor p21WAF1/CIP1, which is normally transcriptionally activated by TGF-β signaling, in glioblastoma and the neuroepithelium (96, 128).